AASLD: New HCV Drug Speeds Viral Clearance (CME/CE)
BOSTON (MedPage Today) — Adding the investigational polymerase inhibitor ANA958 to standard care speeded up the clearance of hepatitis C, compared with standard care alone, a researcher reported here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com